StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$63.65−0.23 (-0.36%)

Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –

Eton Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Eton Pharmaceuticals's cash was $26.85M at Jun 30, 2026. For fiscal 2025 it was $25.94M, up 73.7% from the year before. The highest annual figure on record is $26.74M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.94M+73.7%
FY2024Dec 31, 2024$14.94M-30.2%
FY2023Dec 31, 2023$21.39M+31.2%
FY2022Dec 31, 2022$16.31M+13.2%
FY2021Dec 31, 2021$14.41M-32.4%
FY2020Dec 31, 2020$21.30M+76.5%
FY2019Dec 31, 2019$12.07M-54.9%
FY2018Dec 31, 2018$26.74M+103.2%
FY2017Dec 31, 2017$13.16M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$26.85M+5.8%
Q1 FY2026Mar 31, 2026$19.66M+12.9%
Q4 FY2025Dec 31, 2025$25.94M+73.7%
Q3 FY2025Sep 30, 2025$37.12M+83.2%
Q2 FY2025Jun 30, 2025$25.38M+43.4%
Q1 FY2025Mar 31, 2025$17.42M+4.6%
Q4 FY2024Dec 31, 2024$14.94M-30.2%
Q3 FY2024Sep 30, 2024$20.26M-8.2%
Q2 FY2024Jun 30, 2024$17.69M-18.0%
Q1 FY2024Mar 31, 2024$16.66M+13.2%
Q4 FY2023Dec 31, 2023$21.39M+31.2%
Q3 FY2023Sep 30, 2023$22.07M+65.0%
Q2 FY2023Jun 30, 2023$21.57M+26.5%
Q1 FY2023Mar 31, 2023$14.71M-3.4%
Q4 FY2022Dec 31, 2022$16.31M+13.2%
Q3 FY2022Sep 30, 2022$13.38M-41.1%
Q2 FY2022Jun 30, 2022$17.05M-33.9%
Q1 FY2022Mar 31, 2022$15.23M-39.4%
Q4 FY2021Dec 31, 2021$14.41M-32.4%
Q3 FY2021Sep 30, 2021$22.71M+209.7%
Q2 FY2021Jun 30, 2021$25.80M+151.2%
Q1 FY2021Mar 31, 2021$25.11M+103.6%
Q4 FY2020Dec 31, 2020$21.30M+76.5%
Q3 FY2020Sep 30, 2020$7.33M-37.7%
Q2 FY2020Jun 30, 2020$10.27M-31.3%
Q1 FY2020Mar 31, 2020$12.34M-37.0%
Q4 FY2019Dec 31, 2019$12.07M-54.9%
Q3 FY2019Sep 30, 2019$11.78M+78.4%
Q2 FY2019Jun 30, 2019$14.95M+33.3%
Q1 FY2019Mar 31, 2019$19.58M+48.9%
Q4 FY2018Dec 31, 2018$26.74M+87.9%
Q3 FY2018Sep 30, 2018$6.60M–
Q1 FY2018Mar 31, 2018$11.22M–
Q4 FY2017Dec 31, 2017$13.16M–
Q3 FY2017Sep 30, 2017$14.23M–

More Eton Pharmaceuticals figures

See a number that looks wrong?